Clinical Trial Update: Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers [Phase 1]

View source ↗

Summary

This Phase 1 study update characterizes how adult Hemophilia A carriers respond in the laboratory to desmopressin (DDAVP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• DDAVP (desmopressin acetate)

Snippet

Sponsor: Emory University | Conditions: Hemophilia A | Phase 1 | Status: COMPLETED